Journal of Pharmacy and Pharmacology · 2021 · 25 citations · 27 references
Life SciencesCancer BiologyPharmacologyApoptosisAutophagyMolecular OncologyApoptosis In CancerApoptosis RegulationAutophagy In CancerCancer Cell SignalingCancer Stem Cell BiologyCancer Stem CellsAnticancer ActivityAnticancer Natural ProductsCancer Cell ApoptosisCancer Stem-like CellsMammalian Target Of Rapamycin SignalingPhosphoinositide 3-Kinase PathwayPhosphoinositide 3-Kinase SignalingPi3k-akt-mtor Signaling
OBJECTIVES: To evaluate the anticancer effects of lupeol in retinoblastoma cells. METHODS: WERI-Rb-1 and Y-79 cell lines were used to evaluate the anticancer effect of lupeol. After lupeol treatment, the viability, proliferation, apoptosis, cancer stem-like properties, autophagy and in vivo tumour xenograft formation were detected. KEY FINDINGS: In this study, lupeol decreased cell viability in both WERI-Rb-1 and Y-79 cell lines. Lupeol could also inhibit proliferation and induce apoptosis of RB cells, with increased Bax level and decreased Ki67, survivin and Bcl-2 levels. Furthermore, lupeol could suppress the spheroid formation and stem-like properties of RB cells. Moreover, LC3 II/LC3 I ratio and the levels of Beclin1 and ATG7 were increased after lupeol treatment, indicating that lupeol could induce autophagy in RB cells. Next, the inhibitory effect of lupeol on the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin pathway was observed. In tumour-bearing mice, lupeol suppressed tumour growth, and this might relate to its role in cell apoptosis, autophagy and stem-like properties. CONCLUSIONS: Lupeol suppressed proliferation and cancer stem-like properties, and promoted autophagy and apoptosis of RB cells by restraining the PI3K/AKT/mTOR pathway.
27
Lupeol modulates NF-κB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice
Mohammad Saleem, Farrukh Afaq, Vaqar M. Adhami et al. · Oncogene · 2004 · 248 citations
Medicine, Dermatology, Oncology +13
Cancer stem cell characteristics in retinoblastoma.
Gail M. Seigel, Lorrie M. Campbell, Malathi Narayan · PubMed · 2005 · 172 citations
Medicine, Cell Biology, Oncology +14
Imtıyaz Murtaza, Mohammad Saleem, Vaqar M. Adhami et al. · Cancer Research · 2009 · 95 citations · Full text
Medicine, Oncology, Pharmacology +17